Follow-up Analyses Rekindle Debate On The Impact Of COURAGE
This article was originally published in The Gray Sheet
Executive Summary
Cardiologists are not finished picking apart the controversial COURAGE study. Nine new sub-analyses of the highly-publicized trial were presented last week at the American Heart Association's Scientific Sessions in Orlando
You may also be interested in...
Quality-Of-Life Data Favor Stenting Over Drugs Only In Short-Term
A newly published quality-of-life analysis from the high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease
Quality-Of-Life Data Favor Stenting Over Drugs Only In Short-Term
A newly published quality-of-life analysis from the high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease
Hospital Suppliers Show Vigor In ’07, With Prospects Strong For ’08 – Index
Baxter and Becton Dickinson were among large-cap hospital supply firms to prove that boring can be beautiful in 2007, as med-tech investors turned off by volatility in the sexier cardiac implant sector turned on to the relative stability of diversified, low-risk hospital products with respectable growth